Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Perkov V."'
Autor:
Lemdani K; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.; Sanofi, Marcy-L'étoile, France., Marlin R; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Mayet C; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Perkov V; Sanofi, Marcy-L'étoile, France., Pascal Q; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Ripoll M; Sanofi, Marcy-L'étoile, France., Relouzat F; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Dhooge N; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Bossevot L; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Dereuddre-Bosquet N; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Dargazanli G; Integrated Drug Discovery, Sanofi, Chilly-Mazarin, France., Thibaut-Duprey K; Sanofi, Marcy-L'étoile, France., Haensler J; Sanofi, Marcy-L'étoile, France., Chapon C; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Prost C; Sanofi, Marcy-L'étoile, France. christine.prost@sanofi.com., Le Grand R; Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France. roger.le-grand@cea.fr.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2024 Jun 20; Vol. 9 (1), pp. 113. Date of Electronic Publication: 2024 Jun 20.
Autor:
Perkov, V.1 v.perkov@uni-svishtov.bg
Publikováno v:
Trakia Journal of Sciences. 2021 Supplement, Vol. 19, p34-39. 6p.
Autor:
Broudic K; Research and Development, Sanofi, Marcy l'Etoile, France., Laurent S; Research and Development, Sanofi, Montpellier Cedex, France., Perkov V; Research and Development, Sanofi, Marcy l'Etoile, France., Simon C; Research and Development, Sanofi, Marcy l'Etoile, France., Garinot M; Research and Development, Sanofi, Marcy l'Etoile, France., Truchot N; France Safety Assessment SAS, Charles River Laboratories, Saint-Germain-Nuelles, France., Latour J; Research and Development, Sanofi, Marcy l'Etoile, France., Désert P; Research and Development, Sanofi, Marcy l'Etoile, France.
Publikováno v:
Journal of applied toxicology : JAT [J Appl Toxicol] 2024 Mar; Vol. 44 (3), pp. 371-390. Date of Electronic Publication: 2023 Sep 18.
Autor:
Perkov, V.1 v.perkov@unisvishtov.bg
Publikováno v:
Trakia Journal of Sciences. 2020 Supplement, Vol. 18, p576-581. 6p.
Autor:
Bernard MC; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Bazin E; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Petiot N; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Lemdani K; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Commandeur S; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Verdelet C; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Margot S; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Perkov V; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Ripoll M; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Garinot M; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Ruiz S; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Boudet F; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Rokbi B; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France., Haensler J; Sanofi R&D, Campus Mérieux, 1541 Avenue Marcel Mérieux, 69280 Marcy l'Etoile, France.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 May 08; Vol. 32, pp. 794-806. Date of Electronic Publication: 2023 May 08 (Print Publication: 2023).
Autor:
Ripoll M; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France; Laboratoire de Conception et Application de Molécules Bioactives, Equipe 3Bio (Biovectorisation, Bioconjugaison, Biomatériaux), UMR 7199 - CNRS/Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401, Illkirch Cedex, France. Electronic address: manon.ripoll-ext2@sanofi.com., Bernard MC; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France. Electronic address: marie-clotilde.bernard@sanofi.com., Vaure C; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France. Electronic address: celine.vaure@sanofi.com., Bazin E; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France. Electronic address: emilie.bazin2@sanofi.com., Commandeur S; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France. Electronic address: sylvie.commandeur@sanofi.com., Perkov V; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France. Electronic address: vladimir.perkov@sanofi.com., Lemdani K; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France; Neovacs, 3 impasse Reille, 75014 Paris, France. Electronic address: klemdani@neovacs.com., Nicolaï MC; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France. Electronic address: marie-claire.nicolai@sanofi.com., Bonifassi P; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France. Electronic address: patrick.bonifassi@sanofi.com., Kichler A; Laboratoire de Conception et Application de Molécules Bioactives, Equipe 3Bio (Biovectorisation, Bioconjugaison, Biomatériaux), UMR 7199 - CNRS/Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401, Illkirch Cedex, France. Electronic address: kichler@unistra.fr., Frisch B; Laboratoire de Conception et Application de Molécules Bioactives, Equipe 3Bio (Biovectorisation, Bioconjugaison, Biomatériaux), UMR 7199 - CNRS/Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401, Illkirch Cedex, France. Electronic address: frisch@unistra.fr., Haensler J; Sanofi R&D, Campus Mérieux, 1541 avenue Marcel Mérieux, 69280, Marcy l'Etoile, France. Electronic address: jean.haensler@sanofi.com.
Publikováno v:
Biomaterials [Biomaterials] 2022 Jul; Vol. 286, pp. 121570. Date of Electronic Publication: 2022 May 07.
This study investigated two groups of GABAergic non-pyramidal cells: parvalbumin (PV) fast- skipping (FS) cells with morphology of basket or chandelier neurons and calbindin D28k (CB) positive cells marked as non fast-skipping (NFS) with vertically o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::911b25c5102214cb48869419fab1f026
https://www.bib.irb.hr/597518
https://www.bib.irb.hr/597518
Autor:
Shoja Doost, Janan1 (AUTHOR) jshojado@uoguelph.ca, Fazel, Fatemeh1 (AUTHOR), Boodhoo, Nitish1 (AUTHOR), Sharif, Shayan1 (AUTHOR) shayan@uoguelph.ca
Publikováno v:
Viruses (1999-4915). Sep2024, Vol. 16 Issue 9, p1404. 14p.
Could the Spike Protein Derived from mRNA Vaccines Negatively Impact Beneficial Bacteria in the Gut?
Autor:
Rubio-Casillas, Alberto1,2 (AUTHOR) alberto.rubio@sems.udg.mx, Fabrowski, Mark3 (AUTHOR), Brogna, Carlo4 (AUTHOR) dir.brogna@craniomed.it, Cowley, David5 (AUTHOR) dcowley@lincoln.ac.uk, Redwan, Elrashdy M.6,7,8 (AUTHOR) lradwan@kau.edu.sa, Uversky, Vladimir N.9 (AUTHOR) alberto.rubio@sems.udg.mx
Publikováno v:
COVID. Sep2024, Vol. 4 Issue 9, p1368-1378. 11p.
Autor:
Sheikhlary, Sara1 (AUTHOR) sheikhlary@arizona.edu, Lopez, David Humberto2 (AUTHOR) davidlopez3@arizona.edu, Moghimi, Sophia2 (AUTHOR) sophiam2@arizona.edu, Sun, Bo2 (AUTHOR) sheikhlary@arizona.edu
Publikováno v:
Biomolecules (2218-273X). Apr2024, Vol. 14 Issue 4, p503. 38p.